Cipla LtdNSE: CIPLA

Press Release May 05 2021

· Issued by Cipla Ltd

Filed with NSE · · 4 pages · English

Release

Cipla Limited has informed the Exchange regarding a press release dated May 05, 2021, titled "Roche receives Emergency Use Authorisation in India for its investigational Antibody Cocktail (Casirivimab and Imdevimab) used in the treatment of Covid-19".

Cipla Ltd on 6ix

Earlier from Cipla

Later from Cipla

All Cipla news releases